U.S. FTC allows Amgen to go ahead with $27.8 billion Horizon deal

This post was originally published on this site

https://i-invdn-com.investing.com/trkd-images/LYNXMPEJ801P1_L.jpg

The FTC filed a lawsuit on May 16 aimed at stopping the transaction, but suspended its challenge in late August. The suspension enabled the agency to consider whether it should settle the case.

The Thousand Oaks, California-based company announced plans to buy Horizon in December last year.

Horizon’s shares rose 2.8% in premarket trading.